Efficacy of combined prophylactic therapy (rifaximine alpha + prebiotic arabinogalactan with lactofferin) on GUT function in patients with diagnosed symptomatic uncomplicated diverticular disease.

Abdominal Pain / drug therapy Adult Child Combined Modality Therapy Dietary Supplements Diverticular Diseases / drug therapy Dose-Response Relationship, Drug Drug Administration Schedule Female Gastrointestinal Agents / therapeutic use Gastrointestinal Microbiome Humans Intestine, Small / metabolism Male Middle Aged Mucoproteins / therapeutic use Plant Proteins / therapeutic use Rifaximin / therapeutic use
SUDD arabinogalactan with lactoferrin combined prophylactic therapy Xifaxan plus Fibraxine diverticular disease rifaximine alpha

Journal

Polski przeglad chirurgiczny
ISSN: 2299-2847
Titre abrégé: Pol Przegl Chir
Pays: Poland
ID NLM: 0376426

Informations de publication

Date de publication:
31 Aug 2019
Historique:
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 18 2 2020
Statut: ppublish

Résumé

.

Identifiants

DOI: 10.5604/01.3001.0013.4115 PMID: 31481638
pubmed: 31481638
doi: 10.5604/01.3001.0013.4115
pii: 01.3001.0013.4115
doi:

Substances chimiques

Gastrointestinal Agents 0
Mucoproteins 0
Plant Proteins 0
arabinogalactan proteins 0
Rifaximin L36O5T016N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Tomasz Banasiewicz (T)

Klinika Chirurgii Ogólnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny w Poznaniu, Poznań.

Jacek Paszkowski (J)

Klinika Chirurgii Ogólnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny w Poznaniu, Poznań.

Maciej Borejsza-Wysocki (M)

Klinika Chirurgii Ogólnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny w Poznaniu, Poznań.

Adam Bobkiewicz (A)

Klinika Chirurgii Ogólnej, Endokrynologicznej i Onkologii Gastroenterologicznej Szpitala Klinicznego im. Heliodora Święcickiego w Poznaniu, Poznań.

Anna Pietrzak (A)

Klinika Gastroenterologii i Hepatologii, Centrum Medyczne Kształcenia Podyplomowego, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warszawa.

Marek Szczepkowski (M)

Klinika Chirurgii Kolorektalnej, Ogólnej i Onkologicznej, Centrum Medycznego Kształcenia Podyplomowego, Warszawa.

Wojciech Francuzik (W)

Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes digestifs › Douleur abdominale › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Thérapeutique › Association thérapeutique › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Aliments et boissons › Aliments › Compléments alimentaires › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Gastroentérite › Maladies diverticulaires › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Calendrier d'administration des médicaments › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents gastro-intestinaux › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Biote › Microbiote › Microbiome gastro-intestinal › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Système digestif › Tube digestif › Intestins › Intestin grêle › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Glycoprotéines › Mucoprotéines › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines végétales › Efficacy of combined prophylactic therapy...
questionsmedicales.fr › Composés polycycliques › Composés macrocycliques › Lactames macrocycliques › Rifamycine › Rifaximine › Efficacy of combined prophylactic therapy...